Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00728039
Other study ID # 07/82
Secondary ID GC 399
Status Completed
Phase N/A
First received July 31, 2008
Last updated October 23, 2017
Start date April 2007
Est. completion date July 2017

Study information

Verified date October 2017
Source Medical College of Wisconsin
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

1. Characterize the quality of life of young children with CVS (i.e., psychological, social, physical, school functioning) and the impact of the child's illness on the parent's and family's quality of life (i.e., emotional, social, cognitive functioning, communication, worry, daily activities and family relationships).

2. Assess symptoms of depression, anxiety, ADHD and behavioral problems in what our preliminary data suggests is a psychiatrically vulnerable population.

3. Evaluate the associations between quality of life and psychiatric symptoms and the frequency and intensity of CVS attacks.

4. Use the data generated from this study to develop a psychosocial intervention targeted at young children with CVS and their families who evidence risk for functional disability, with the aim of intervening as early as possible to limit the psychological and social morbidity experienced by children with CVS and their and families.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 9 Years to 18 Years
Eligibility Inclusion Criteria:

- Diagnosis of CVS

Exclusion Criteria:

- Children and parents who are not English speaking

- Youth with significant developmental delay, mental retardation, psychotic symptoms, or other significant mental impairments and those with other major medical disorders such as IDDM, congenital heart disease, cystic fibrosis, etc.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Medical College of Wisconsin Children's Hospital and Health System Foundation, Wisconsin

Outcome

Type Measure Description Time frame Safety issue
Primary Characterize the quality of life of youth with CVS as well as the strategies they use to cope with stress, their strengths and vulnerabilities, and to assess symptoms of depression and anxiety in these at risk youth. Two years
Secondary Evaluate the associations among coping strategies the frequency and intensity of CVS attacks to determine if particular coping styles and personal characteristics are associated illness severity, psychiatric co-morbidity and quality of life. Two years
See also
  Status Clinical Trial Phase
Completed NCT00728026 - Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea N/A
Completed NCT00743665 - Quality of Life And Psychological Symptoms In Children With Cyclic Vomiting Syndrome (CVS)